ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

No reading has been made of this study yet; what is shown is how the rules link it today.

7 links0 made here, not in the record7 judgments1 judge (the rules as one: Rule based)0 record changes seen
Rule based
Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT05754684Quadruple Immunotherapy forNeuroblastomaHong Kong Children's HospitalPhase 2 · recruitingRECORDThe record itselfVersions seen nightly since Sep 25, 2…›No new version seen since tracking began Sep 25, 2026.CONDITIONSNeuroblastomaNo longer in the registry's filing›As of now · Rule based · Main conditionMain conditionDRUGSNatural Killer CellIntervention entry›As of now · Rule based · TestedTestedDinutuximabEntry “Dinutuximab beta”, read by our…›As of now · Rule based · TestedTestedInterleukin-2Intervention entry›As of now · Rule based · TestedTestedGranulocyte-Macrophage Colo…Intervention entry›As of now · Rule based · TestedTestedSpironolactoneIntervention entry›As of now · Rule based · TestedTestedNaxitamabIntervention entry›As of now · Rule based · TestedTested

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

Neuroblastoma

From the registry record1 judgment on this link
Main condition (R9), from the registry to what was judged
RegistryNeuroblastoma, once filedthe registry files the study under it
→judged→
On the pageNo longer linkedthe registry no longer files it here

All judgments on this study

WhenLinkJudgeDecisionState
As of nowNeuroblastomaRule based · main-condition ruleMain conditionCurrent
As of nowNatural Killer CellRule based · role ruleTestedCurrent
As of nowDinutuximabRule based · role ruleTestedCurrent
As of nowInterleukin-2Rule based · role ruleTestedCurrent
As of nowGranulocyte-Macrophage Colony-Stimulating FactorRule based · role ruleTestedCurrent
As of nowSpironolactoneRule based · role ruleTestedCurrent
As of nowNaxitamabRule based · role ruleTestedCurrent

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

Which drugs a study tests

Reads each treatment the study lists and the arms it is in. A drug only in the experimental arm is tested. A drug in every arm while something else changes between the arms is given beside it. A drug only in the control arm is the comparator. Placebo, procedures and usual care are known by name.

Where the whole record has been read, that reading's answer replaces the rule's.

What a study is mainly about

Starts from the first condition ClinicalTrials.gov files the study under. It moves to a narrower one only when the study's own title or listed conditions name it, and sets aside terms the registry often files by mistake. A study open to many cancers is not placed under one of them unless its title names it.

Checked against studies judged one by one; the study page says when it differs from the registry.